Wang Y, Li L, Yang M, Liu H, Boden G, Yang G
Studies are evaluating its potential role in appetite control, fat metabolism, insulin regulation, and energy expenditure
Given the neuroprotective effects of both GLP-1 and estradiol, it would also be interesting to know how such agents might reduce neurodegeneration, especially in menopausal women
Each treatment is safe for all skin types and requires no downtime
What Providers Evaluate: Medical Appropriateness: BMI eligibility criteria (BMI 30, or BMI 27 with weight-related condition) Contraindications that make GLP-1 unsafe Overall health status and medical complexity Safer or more appropriate alternatives Safety Considerations: Medication interactions with current prescriptions Health conditions that increase risk Ability to safely self-administer Need for additional monitoring or specialist involvement Mental health stability Patient Understanding: Understanding of how medications work and timeline Realistic expectations about gradual weight loss Awareness of side effects and management Commitment to follow-up care and long-term duration Financial ability to sustain treatment Understanding this is not a cure-weight typically regains when medication stops If Approved: Prescription transmitted to pharmacy, confirmation with timeline, medication preparation begins If Not Approved: Provider explains medical reasons, suggests alternatives if applicable, full refund per policy if medically disqualified (unless disqualifying criteria knowingly omitted) This approval process separates legitimate platforms from operations that auto-approve without genuine evaluation
